Related Experiment Videos
Neoplasms of the bladder, prostate, and testis
J P Heiken1, H P Forman, J J Brown
1Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri.
Radiologic Clinics of North America
|January 1, 1994
Summary
Imaging tests like CT, MRI, and ultrasound are crucial for staging male urologic cancers, including bladder, prostate, and testicular cancers. Further clinical trials are needed to optimize their use in future cancer staging.
Area of Science:
- Urologic oncology
- Medical imaging
- Cancer staging
Background:
- Carcinomas of the urinary bladder, prostate, and testis constitute over one-third of male cancers.
- Accurate staging is critical for effective treatment planning and patient outcomes.
Purpose of the Study:
- To review the current roles of various imaging modalities in staging male urologic cancers.
- To highlight the importance of imaging in the management of bladder, prostate, and testicular cancers.
Main Methods:
- Computed tomography (CT) for postorchiectomy staging of testicular cancer.
- Transrectal ultrasonography (TRUS) and magnetic resonance imaging (MRI) for prostate cancer staging.
- MRI, CT, and transurethral ultrasonography (TUS) for bladder cancer staging.
Main Results:
- CT is the preferred imaging modality for testicular cancer staging after orchiectomy.
- TRUS and MRI are vital for accurate prostate cancer staging.
- MRI, CT, and TUS provide essential information for staging bladder cancer.
Conclusions:
- Current imaging techniques offer valuable data for staging male urologic cancers.
- Well-designed clinical trials are necessary to establish evidence-based guidelines for optimal imaging test utilization in bladder and prostate cancer staging.